Godavari Drugs Approves Rs 340 Million Working Capital Facility From ICICI Bank
Godavari Drugs Ltd 路 Others (Uncategorized) 路 14 Oct 2026, 10:06 pm
Godavari Drugs Approves Rs 340 Million Working Capital Facility From ICICI Bank Godavari Drugs Limited's Board of Directors approved availing working capital credit facilities aggregating up to Rs 340.00 Mn from ICICI Bank Ltd on 14th Oct'26. The limits include provisions for temporary overdrafts or accommodations alongside security creation as outlined in the bank's arrangement letter dated 12th Oct'26. Managing Director Mukund Kakani has been authorized to execute the necessary documentation. The company confirmed that the facility remains within previously approved shareholder borrowing limits under Section 180(1)(c) of the Companies Act, 2013.
Original exchange filing (PDF)
More announcements from Godavari Drugs Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sushma Kakani 路 18 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mohit Jaju 路 17 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mukund Kakani 路 17 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aksheit Kakani 路 17 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tanushree Kakani 路 17 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kamala Jaju 路 17 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ghanshyam Jaju 路 17 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Priyanka Jaju 路 17 Nov 2026
